KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Assets (2016 - 2025)

Historic Assets for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $40.7 billion.

  • Teva Pharmaceutical Industries' Assets rose 361.59% to $40.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $40.7 billion, marking a year-over-year increase of 361.59%. This contributed to the annual value of $40.7 billion for FY2025, which is 361.59% up from last year.
  • As of Q4 2025, Teva Pharmaceutical Industries' Assets stood at $40.7 billion, which was up 361.59% from $39.9 billion recorded in Q3 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Assets registered a high of $49.2 billion during Q2 2021, and its lowest value of $38.4 billion during Q1 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' median Assets value was $43.3 billion (recorded in 2023), while the average stood at $43.6 billion.
  • Its Assets has fluctuated over the past 5 years, first tumbled by 1143.32% in 2021, then soared by 361.59% in 2025.
  • Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Assets stood at $47.7 billion in 2021, then decreased by 7.67% to $44.0 billion in 2022, then decreased by 1.21% to $43.5 billion in 2023, then fell by 9.55% to $39.3 billion in 2024, then grew by 3.62% to $40.7 billion in 2025.
  • Its last three reported values are $40.7 billion in Q4 2025, $39.9 billion for Q3 2025, and $40.1 billion during Q2 2025.